In vitro and in vivo targeting imaging of pancreatic cancer using a Fe(3)O(4)@SiO(2) nanoprobe modified with anti-mesothelin antibody

Pancreatic cancer is a highly malignant disease with a 5-year survival rate <5% mainly due to lack of early diagnosis and effective therapy. In an effort to improve the early diagnostic rate of pancreatic cancer, a nanoprobe Fe(3)O(4)@SiO(2) modified with anti-mesothelin antibody (A-MFS) was prep...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Le, Wenjun, Mei, Tianxiao, Wang, Tiegong, Chen, Luguang, Lei, Yi, Cui, Shaobin, Chen, Bingdi, Cui, Zheng, Shao, Chengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876944/
https://www.ncbi.nlm.nih.gov/pubmed/27274243
http://dx.doi.org/10.2147/IJN.S104501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876944/
https://www.ncbi.nlm.nih.gov/pubmed/27274243
http://dx.doi.org/10.2147/IJN.S104501

Ejemplares similares